PURR
Hyperliquid Strategies Inc
$8.76-9.60%
Setup
No setup
Buy Zone
$8.62-$9.05
Sector
Capital Markets
Industry
Capital Markets
71
Recommendation
No setup
Hold
No active chart path confirmed. Keep on watchlist until price, volume, and setup align.
PURR chart
Loading chart…
Overall Quality71
RS Rating
50
relative strength
Fundamentals
97
Strong fund-Q
Volume Demand
68
+42% vs avg
Technical Setup
38
3/8 checks
Industry/Theme
91
Capital Markets
Trade Plan
No setup
Entry
$8.62
Entry Zone
$8.62-$9.05
Stop / Risk
$7.93
RS Rating
50
Volume confirmed
No
Targets
$10.34 / $10.77
Breakout · IBD Setup
2 ✓ 6 ✗
Entry $8.62–$9.05Stop $7.93Target $10.34 / $10.77
Market regimeRange
Quality71
RS Rating50
Above 50-MA-22.49%
Above 200-MA+12.65%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
71
MarketRange
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q97 · Strong
StatusHold
Stock Data
52-Week Range3 – 15
Price % Chg YTD146.07%
Price % Chg 4wk-25.32%
50-Day Avg Vol19.9 Mil
P/E Ratio16.9
Market Cap$3B
SectorFinancial
IndustryCapital Markets
Company Fundamentals
EPS % Chg (Qtr)43889.58%
Sales % Chg (Qtr)—
EPS Growth 5y—
Sales Growth 5y—
Annual ROE33.94%
Gross Margin—
Operating Margin-60.1%
Net Margin2552.32%
Debt / Equity0.00
Setup levels
Current price
$8.76
Pivot
$8.62
Distance to buy
-40.6%
52-week range
3.01-14.76
Trigger evidence
No active trigger evidence available.
Financial health checks
4/4
Return on equity above 15%
ROE 33.94%
Net margin above 10%
Net margin 2552.32%
EPS growing quarter on quarter
EPS q/q 43889.58%
Debt to equity below 1.0
D/E 0.00
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE33.94%
vs sector +18.6%
Net margin2552.32%
vs sector +2532.2%
Gross margin—
EPS growth q/q43889.58%
vs sector +43872.4%
Sales growth q/q—
Debt / equity0.00
vs sector -2.75
Business quality
97
GradeStrong
EPS rating99
P/E16.9
Market cap$3B
IndustryCapital Markets
Technical checks
Über 50-MA
Fail
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Fail
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-10-30
Trigger date
—
Days on list
7
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.